News

As a potential alternative to antibiotic treatments, this investigational immunization offered protection for several years.

Evaluating the importance of RSV vaccination implications for adults.

Emergency use authorization for CorDx TyFast Flu A/B & COVID-19.

FDA approves Zevtera a new treatment option for bacterial infections, a comprehensive look at coccidioidomycosis, the impact of guidelines on reducing hospital-onset CDI incidence, and more this week from Contagion.

The case involves a man who had contact with wild monkeys.

Dr. Thomas Holland discusses the breakthrough in antibiotic development.

During the 2014-2016 African epidemic, investigational Ebola vaccines demonstrated safety and immunogenicity.

Alcohol Awareness Month highlights the need for action amidst the alcohol crisis in the US.

An FDA decision on the company’s mRNA-1345 is slated for May 12.

Examining the implications and challenges of coccidioidomycosis, histoplasmosis, and blastomycosis diagnosis during the COVID-19 pandemic.

The RSV prefusion F protein–based maternal vaccine phase 3 trial was halted due to the risk of this adverse event.

Zevtera approval shows efficacy and marks a new treatment option for bacterial infections including MRSA.

Here is a case study involving a patient with the virus and the clinical approach in thinking about appropriate treatment while keeping stewardship in mind.

A comprehensive look at coccidioidomycosis (valley fever) through diagnosis, treatment, prevention, and climate change impact.

Community acquired pneumonia is often inappropriately diagnosed in hospital admissions, particularly among older adults with dementia, and can lead to in-hospital antibiotic-associated adverse events, such as Clostridioides difficile.

Bavarian Nordic's JYNNEOS available to healthcare providers nationwide.

The case was confirmed in Texas and the person was in contact with cows. CDC says the risk for infection remains low.

April marks STI Awareness Month; guidelines decreasing the incidence of chlamydia and syphilis, future work needing to be done with regards to doxy-PEP, an increase in STIs during the pandemic, and more from this year by Contagion.

This very large study reviewed data, which showed people vaccinated for the virus had a substantial reduction of risk for these types of events.

Rising dengue incidence in Puerto Rico signals broadening health concerns.

Clinicians review a patient case including diagnosis, treatment, and follow-up.

A study on the impact of guidelines on reducing hospital-onset CDI incidence.

Clinicians discuss screening and treatment approaches for the disease.

FDA authorizes Ito Invivyd’s pemivibart (Pemgarda), insights on Sofosbuvir levels in pregnant women, the effectiveness of fidaxomicin vs vancomycin for CDI treatment, and more this week from Contagion.

A surge in meningococcal disease cases linked to Serogroup Y.

The company's latest investigational vaccine induced a greater immune response compared to its FDA approved Spikevax product.

Impact of the RSVPreF3 vaccine on respiratory illness in older adults in the US.

Atea Pharmaceuticals bemnifosbuvir aims to help high-risk COVID-19 patients with a new oral option.

A study conducted in China aimed to assess factors such as viral load rebound (VLR), reduction in cycle threshold values, time until VLR, and symptom rebound.

Phase 2 study of healthcare workers' safety in high-risk populations.